What's new at the NMI? What is happening at the NMI and in the research landscape?Find out more about the NMI!
Dr.-Ing. René von Metzen, department head at the NMI, was elected spokesperson for the Micro Medical Technologies Expert Group ...
Since November 2020, the NMI is a partner in the international ZIM network "4D Bioprinting" (FKZ 16KN098801). This network consists of European SMEs and research institutions that are jointly researching innovative bio inks and ...
Kathrin Stadelmann, scientist of the Biomedical Micro and Nano Engineering group at the NMI, won the second prize at the Young Scientists Lecture.
A nationwide antibody study by the Helmholtz Centre for Infection Research (HZI) was launched in the district of Reutlingen at the beginning of July with the aim of gaining a better overview of the occurrence of SARS-CoV-2 infections.
While the Innovation Alliance Baden-Württemberg, in short innBW, can already look back on a long history, the 13 member institutes joined together to form an association on 24 June.
The NMI is collaborating in an international project consortium named CORESMA in which clinical, epidemiological and immunological data will be collected and triangulated to assist healthcare systems in their effort to make evidence-based decisions regarding the corona Crisis.
The NMI Reutlingen is currently tackling a major problem associated with antibody tests for the detection of COVID-19: false positive test results.
NMI supports the University Hospital of Tübingen in clarifying the material question.
The NMI Natural and Medical Sciences Institute at the University of Tübingen is focusing its research efforts into infections with the novel coronavirus (SARS-CoV-2).
Together with Proteona and Synovo, the NMI will use its platform for patient-derived microtumours for drug screening and the discovery of potential drug candidates.
In order to protect individuals as well as society as a whole, the NMI has also taken measures to protect employees in the light of the corona pandemic.
In cooperation with the medical technology company Joline, in the future the NMI will conduct research on central venous catheters that have an antibacterial effect due to their water-loving surface. A positive side effect: the researchers expect that the new surface will also significantly reduce the risk of thrombosis.
Durch die Nutzung dieser Webseite erklären Sie sich mit der Verwendung von Cookies einverstanden. Detaillierte Informationen über den Einsatz von Cookies auf dieser Webseite erhalten Sie in der Datenschutzerklärung.
Tools, die wesentliche Services und Funktionen ermöglichen, einschließlich Identitätsprüfung, Servicekontinuität und Standortsicherheit. Diese Option kann nicht abgelehnt werden.
Tools, die anonyme Daten über Website-Nutzung und -Funktionalität sammeln. Wir nutzen die Erkenntnisse, um unsere Produkte, Dienstleistungen und das Benutzererlebnis zu verbessern.
Integration von Social Media Plugins.